Provention Bio, Inc.
PRVBNASDAQHealthcare
$24.98
+$0.00(+0.00%)
Market Cap$2.4B
P/E Ratio—
52W High$25.0
52W Low$3.185
Provention Bio, Inc. (PRVB) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
PRVB · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2023Report Date: Mar 29, 2023EPS Actual
-$0.38
Est. -$0.31 · -22.6%
Revenue
$0.01B
Est. $0.01B · +30.3%
Fiscal Period
Q1 FY2023
FY ends December
Report Date
Mar 29, 2023
After Market Close
▼ Miss EPS▲ Beat Revenue
PRVB reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q1 FY2024 | Mar 27, 2024 | — | — | — | — | — | — |
| ◌ Q4 FY2023 | Nov 1, 2023 | — | — | — | — | — | — |
| ◌ Q3 FY2023 | Aug 2, 2023 | -$1.54 | — | — | — | $0.00B | — |
| ◌ Q2 FY2023 | May 4, 2023 | -$0.97 | — | — | — | $0.00B | — |
| ▼ Q1 FY2023 | Mar 29, 2023 | -$0.31 | -$0.38 | -22.6% | $0.01B | $0.01B | +30.3% |
| ▲ Q4 FY2022 | Nov 3, 2022 | -$0.46 | -$0.34 | +26.1% | $0.00B | — | — |
| ▲ Q3 FY2022 | Aug 4, 2022 | -$0.49 | -$0.46 | +6.1% | $0.00B | — | — |
| ▲ Q2 FY2022 | May 5, 2022 | -$0.45 | -$0.35 | +22.2% | $0.00B | $0.00B | -20.3% |
Q1 FY2024
Mar 27, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2023
Nov 1, 2023
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2023
Aug 2, 2023
EPS Actual
—
EPS Est.
-$1.54
EPS Surpr.
—
Revenue
—
Q2 FY2023
May 4, 2023
EPS Actual
—
EPS Est.
-$0.97
EPS Surpr.
—
Revenue
—
Q1 FY2023
Mar 29, 2023Miss
EPS Actual
-$0.38
EPS Est.
-$0.31
EPS Surpr.
-22.6%
Revenue
$0.01B
Q4 FY2022
Nov 3, 2022Beat
EPS Actual
-$0.34
EPS Est.
-$0.46
EPS Surpr.
+26.1%
Revenue
$0.00B
Q3 FY2022
Aug 4, 2022Beat
EPS Actual
-$0.46
EPS Est.
-$0.49
EPS Surpr.
+6.1%
Revenue
$0.00B
Q2 FY2022
May 5, 2022Beat
EPS Actual
-$0.35
EPS Est.
-$0.45
EPS Surpr.
+22.2%
Revenue
$0.00B
No analyst estimates available for PRVB.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q1 FY2023 | Mar 29, 2023 | -22.6% | $23.96 | $24.20 | +1.00% |
| ▲ Q4 FY2022 | Nov 3, 2022 | +26.1% | $6.67 | $8.41 | +26.09% |
| ▲ Q3 FY2022 | Aug 4, 2022 | +6.1% | $3.98 | $4.28 | +7.54% |
| ▲ Q2 FY2022 | May 5, 2022 | +22.2% | $4.93 | $4.75 | -3.65% |
| ▲ Q1 FY2022 | Feb 24, 2022 | +6.8% | $6.41 | $6.35 | -0.94% |
| ▲ Q4 FY2021 | Nov 4, 2021 | +8.5% | $6.66 | $6.44 | -3.30% |
| ▲ Q3 FY2021 | Aug 5, 2021 | +9.8% | $6.02 | $6.60 | +9.63% |
| ▼ Q2 FY2021 | May 6, 2021 | -8.3% | $7.20 | $7.01 | -2.64% |
Q1 FY2023+1.00%
Report Date
Mar 29, 2023
EPS Beat/Miss
-22.6%
Price Before
$23.96
Price After
$24.20
Q4 FY2022+26.09%
Report Date
Nov 3, 2022
EPS Beat/Miss
+26.1%
Price Before
$6.67
Price After
$8.41
Q3 FY2022+7.54%
Report Date
Aug 4, 2022
EPS Beat/Miss
+6.1%
Price Before
$3.98
Price After
$4.28
Q2 FY2022-3.65%
Report Date
May 5, 2022
EPS Beat/Miss
+22.2%
Price Before
$4.93
Price After
$4.75
Q1 FY2022-0.94%
Report Date
Feb 24, 2022
EPS Beat/Miss
+6.8%
Price Before
$6.41
Price After
$6.35
Q4 FY2021-3.30%
Report Date
Nov 4, 2021
EPS Beat/Miss
+8.5%
Price Before
$6.66
Price After
$6.44
Q3 FY2021+9.63%
Report Date
Aug 5, 2021
EPS Beat/Miss
+9.8%
Price Before
$6.02
Price After
$6.60
Q2 FY2021-2.64%
Report Date
May 6, 2021
EPS Beat/Miss
-8.3%
Price Before
$7.20
Price After
$7.01
Avg Beat Reaction+5.90%
Avg Miss Reaction-0.82%
Beat Rate6 / 8 quarters
Largest Move+26.09% (Q4 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: PRVB ends December
Provention Bio, Inc. (PRVB) most recently reported earnings on March 29, 2023 for Q1 FY2023, posting EPS of $-0.38 — missing the analyst consensus of $-0.31 by -22.6%. The next PRVB earnings date is expected around September 1, 2026.
Each quarter, investors track PRVB earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. PRVB revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
PRVB's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
PRVB earnings · 5 questionsProvention Bio, Inc.'s next earnings report is expected around September 1, 2026. PRVB typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; PRVB historically reports after market close (AMC).
PRVB earnings datewhen is PRVB earningsPRVB next earnings datewhen does PRVB report earningsPRVB earnings calendar
▸ Source: FMP · Provention Bio, Inc. SEC filings · US GAAP · Provention Bio, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026